Last updated on 10 Feb, 2026 | 05:15 IST
Rights Ratio | Face Value  | Premium | Ex-Right Date | Record Date  | Announcement Date |
|---|---|---|---|---|---|
| No data found | |||||
*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.
Existing shareholders of EMCURE PHARMACEUTICALS L as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.
Shareholders can apply for EMCURE PHARMACEUTICALS L rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.
No! Participation in EMCURE PHARMACEUTICALS L rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.
No, EMCURE PHARMACEUTICALS L hasn’t had any right issues as of {{current_date}} in last 2023-2025
No, EMCURE PHARMACEUTICALS L hasn’t had any right issues as of {{current_date}} in last 2023-2025